Summary
RMC No. 66-2022 publishes the April 8, 2022 Food and Drug Administration letter endorsing updates to the List of Medical Devices Exempt from VAT under RA No. 11534 (CREATE Act).
Key points
- What the letter covers. The letter comes from FDA OIC-Director General Oscar G. Gutierrez, Jr. and endorses updates to the VAT-exempt medical device list.
- Changes to the list. The list includes, deletes and corrects certain medical devices for COVID-19 treatment.
Deadlines and effectivity
- FDA letter dated April 8, 2022
Summary by Tax Resources PH. It is not a substitute for the full text of the issuance or professional advice.
Copies of BIR issuances are hosted here for reference. For the official version, check bir.gov.ph. Summaries by Tax Resources PH are not a substitute for the full text or professional advice.
